TechCrunch AIT2·Industry
78 pts
Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has closed a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining and all existing backers participating. Building on AlphaFold, its simulation-model engine has produced positive preclinical results in oncology and immunology and underpins deals with Eli Lilly, Novartis and Johnson & Johnson; the new capital is aimed at moving candidates into clinical trials.